ERYTECH Pharma S.A.
ERYP · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$228 | -$53,797 | -$73,300 | -$62,659 |
| Dep. & Amort. | $2,908 | $5,377 | $4,991 | $4,216 |
| Deferred Tax | $521 | $2 | $3 | -$1 |
| Stock-Based Comp. | $447 | $1,323 | $1,179 | $1,359 |
| Change in WC | -$8,098 | -$7,153 | $10,802 | $13,730 |
| Other Non-Cash | -$27,314 | -$2,522 | $4,605 | $45 |
| Operating Cash Flow | -$31,764 | -$56,770 | -$51,720 | -$43,310 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$85 | -$298 | -$1,141 | -$20,133 |
| Net Acquisitions | $0 | $0 | $2 | $16 |
| Inv. Purchases | -$5 | -$192 | -$421 | -$119 |
| Inv. Sales/Matur. | $586 | $145 | $4 | $414 |
| Other Inv. Act. | $37,631 | $0 | $81 | -$16 |
| Investing Cash Flow | $38,127 | -$345 | -$1,475 | -$19,838 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $34,631 | $118 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,768 | $44,712 | $25,449 | $40 |
| Financing Cash Flow | -$1,768 | $44,712 | $25,449 | $40 |
| Forex Effect | $495 | $1,656 | -$981 | $1,910 |
| Net Chg. in Cash | $5,090 | -$10,747 | -$28,727 | -$61,198 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $33,699 | $44,446 | $73,173 | $134,371 |
| End Cash | $38,789 | $33,699 | $44,446 | $73,173 |
| Free Cash Flow | -$31,849 | -$57,068 | -$52,861 | -$63,443 |